Tag Archives: FRANKFURT

puff ventures

PUF Ventures is Added to the Composite Index of the Canadian Securities Exchange

PUF Ventures is Added to the Composite Index of the Canadian Securities Exchange

VANCOUVER, Dec. 16, 2016 /Weed Wire/ — PUF Ventures Inc. (the “Company”) (CSE: PUF) (Frankfurt: PU3) (OTCPK: PUFXF) is very pleased to announce that it has been added to the Canadian Securities Exchange (the “CSE”) Composite Index effective at the close of trading on Friday, December 16, 2016.

Affinor Growers

Affinor Growers Settles $137,910 Debt

VANCOUVER, British Columbia, Aug. 30, 2016 /Weed Wire/ — Affinor Growers (CSE:AFI)(OTCQB:RSSFF)(FRANKFURT:1AF) (“Affinor” or the “Corporation), a diversified agriculture and biotechnology company with proprietary vertical farming systems, announces that the Company settles $137,910 debt with its consultants by issuing 2,758,200 common shares at $0.05 per share.

Veritas Pharma

Veritas Pharma Embarks on Important Next Phase of Cannabis Research

VANCOUVER, Aug. 3, 2016 /Weed Wire/ — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt: 2VP) is pleased to announce that through Cannevert Therapeutics Ltd, Veritas’ research arm, has developed several candidate cannabis strains and is now fully engaged in chemical and biological assessment of these key strains.

Aurora Cannabis operational update

Aurora Announces Q3 2016 Results

VANCOUVER, British Columbia, May 30, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT:21P)(WKN:A1C4WM)(OTCQB:ACBFF) (“Aurora” or the “Company”) announced its financial and operational results for the three and nine month periods ended March 31, 2016. Aurora is a Licensed Producer of medical cannabis under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR).

Aurora Cannabis operational update

Aurora Cannabis Exceeds 3,000 Active Registered Patients in Five Months

VANCOUVER, British Columbia, May 30, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB) (FRANKFURT:21P) (WKN:A1C4WM) (OTCQB:ACBFF) (“Aurora” or the “Company”), announced that the Company has exceeded 3,000 active registered patients over the first five months since commencement of product sales on January 5, 2016.

THC BioMed

Health Canada Grants THC BioMed Oil Production License

THC BioMed Successfully Imports 28 Dutch Cannabis Strains   VANCOUVER, British Columbia, May 24, 2016 /Weed Wire/ — THC BioMed Intl. Ltd. (CSE: THC) (OTC PINK: THCBF) (FRANKFURT: TFHC) is pleased to announce that our wholly-owned subsidiary, THC BioMed Ltd. has been granted authorization by Health Canada to produce fresh marijuana, Cannabis Oil and Cannabis Resin. This license allows us

Aurora Cannabis operational update

Aurora Cannabis Provides Operational Update

VANCOUVER, British Columbia, April 1, 2016 /Weed Wire/ — Aurora Cannabis Inc. (CSE:ACB)(FRANKFURT:21P)(OTCQB:ACBFF) (WKN:A1C4WM) (“Aurora” or the “Company”), a Licensed Producer of medical cannabis under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR), is pleased to provide the following operational update…

Veritas Pharma

Veritas Lists and Increases Private Placement on Bay Street Cannabis Web Portal

VANCOUVER, British Columbia, March 30, 2016 /Weed Wire/ — Veritas Pharma Inc. (CSE: VRT; OTC: VRTHF; and Frankfurt:2VP) announces that the Company’s previously announced private placement has been listed on the newly created online investment platform, Bay Street Cannabis.

Global Hemp Group

Global Hemp Group Announces Frank Giese to Join Advisory Board and to Assist in the Development of the Company’s Genetics Division

VANCOUVER, British Columbia, Feb. 26, 2016 /Weed Wire/ — GLOBAL HEMP GROUP INC. (“GHG” or the “Company”) (CSE: GHG / FRANKFURT: GHG / OTCQB: GBHPF) is pleased to announce that Mr. Frank Giese has joined the Company’s Advisory Board to assist in the development of the newly formed Genetics Division.

THC BioMed

Health Canada Grants THC BioMed Licence to Cultivate Marihuana

VANCOUVER, British Columbia, Feb. 22, 2016 /Weed Wire/ — THC BioMed Intl. Ltd. (CSE:THC) (OTC PINK:THCBF) (FRANKFURT:TFHC) is pleased to announce that our wholly-owned subsidiary, THC BioMed Ltd. has been granted a license to produce medical marihuana under Health Canada’s Marihuana for Medical Purposes Regulations (MMPR).


Top